Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2016

Conditions
Sleep Apnea, Obstructive
Interventions
DRUG

Dronabinol

DRUG

Placebo (for Dronabinol)

Trial Locations (2)

60611

Northwestern University, Chicago

60612

University of Illinois at Chicago, Chicago

All Listed Sponsors
collaborator

Northwestern University

OTHER

collaborator

University of Chicago

OTHER

collaborator

Hektoen Institute for Medical Research

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Illinois at Chicago

OTHER